监测活化部分凝血活酶时间评价血液透析中抗凝药物疗效  

Activated Partial Thromboplastin Time for Anticoagulats Therapy in Hemodialysis

作　　者：靖永胜[1] 刘子栋[1] 朱斌[1] 王小平[1] 马天旻[1] 

机构地区：[1]济南市中心医院

出　　处：《山东医药》1999年第5期3-4,共2页Shandong Medical Journal

摘　　要：在血液透析（ＨＤ）全程中，通过活化部分凝血活酶时间（ＡＰＴＴ）的监测，对１００例行规律ＨＤ患者的肝素使用剂量进行监控。结果显示，在常规ＨＤ中，应控制ＡＰＴＴ超过基础值的８０．１５±５．２７％，透析结束时缩短至超过基础值的４１．０５±６．７２％。这样，既能保证ＨＤ安全进行。The purpose of the subject is to study the value of intracoronary stenting in dealing with acute myocardial infarction(AMI) 20 patients with AMI underwent emergent percutaneous transtuminal coronary angioplasry(PTCA)and inracoronary stent deployment 23 stents were inserted in 21 infarcted related arteries(IRA) The procedure success rate was 100% All patients received anticoagulation therapy after stent placement Thrombolysis in myocardial infarction(TIMI)grade after the procedure achieved 2 flow or greater Diameter stenosis reduced from 89±18% to 12±6%after procedure (P<0 05),remnant stenosis was 8±10% Clinical follow up was available in all patients for 6～18 months after discharge,only one case suffered from reinfarction,the restenosis rate was 14 3% Intracoronary stenting may be an effective and safe method for AMI

关 键 词：血液透析 肝素 APTT 监测 

分 类 号：R459.5[医药卫生—治疗学]